Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending September 18 2022

Healthcare Private Placement and M&A Transactions Review Week Ending September 18 2022

by Jonathan Hodson-Walker | Sep 22, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Galvanize Therapeutics: The company raised $100 million of Series B venture funding in a deal led by Fidelity Management & Research on September 15, 2022. Intuitive Surgical, Gilmartin...
Healthcare Private Placement and M&A Transactions Review Week Ending September 11 2022

Healthcare Private Placement and M&A Transactions Review Week Ending September 11 2022

by Jonathan Hodson-Walker | Sep 13, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions JenaValve Technology: The company received $100 million of development capital from Bain Capital Life Sciences, Peijia Medical, Gimv, Andera Partners, RMM Ventures, Valiance, VI Partners,...
Healthcare Private Placement and M&A Transactions Review Week Ending August 28 2022

Healthcare Private Placement and M&A Transactions Review Week Ending August 28 2022

by Jonathan Hodson-Walker | Aug 30, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Aktis Oncology: The company raised $84 million of Series A venture funding from Novartis, MRL Ventures Fund and Merck & Co. on August 25, 2022. Timefolio Capital, Octagon Capital...
Healthcare Private Placement and M&A Transactions Review Week Ending August 21 2022

Healthcare Private Placement and M&A Transactions Review Week Ending August 21 2022

by Jonathan Hodson-Walker | Aug 23, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Bluejay Therapeutics: The company raised $41 million of Series B venture funding in a deal led by Arkin Bio-Ventures on August 16, 2022, putting the company’s pre-money valuation at $65...
Healthcare Private Placement and M&A Transactions Review Week Ending August 14 2022

Healthcare Private Placement and M&A Transactions Review Week Ending August 14 2022

by Jonathan Hodson-Walker | Aug 18, 2022 | Healthcare

Strategy | Financing Highlight “Three to five years ago, the big strategics were sprinkling money around, but you are now seeing more focus from them,” said Jonathan Hodson-Walker, managing partner of Silverwood Partners, an investment banking firm that advises CPG...
Healthcare Private Placement and M&A Transactions Review Week Ending August 7 2022

Healthcare Private Placement and M&A Transactions Review Week Ending August 7 2022

by Jonathan Hodson-Walker | Aug 10, 2022 | Healthcare

Strategy | Financing Highlight “Three to five years ago, the big strategics were sprinkling money around, but you are now seeing more focus from them,” said Jonathan Hodson-Walker, managing partner of Silverwood Partners, an investment banking firm that advises CPG...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives